Literature >>>

 
Tackling NBIA pain with morphine: Difficult issue requires much thought - April 2004

 
By Dianne Gray

Watching a loved one with NBIA in pain is very difficult, especially when the exact source of the pain isn’t known because the person can’t tell you. Knowing how best to treat that pain can be even harder.

 

My son, Austin, is now 13, but more than three years ago, physicians believed that we were “at the end of the road” and that Austin was certainly near death. During the summer of 2000, he was in tremendous pain from dystonia in his back. Our doctors also said he had extreme bouts of inspiratory strider,  (difficulty breathing due to tightening of the muscles in the throat area), as a result of dystonia in his vocal cords.  At times, he felt like he was suffocating.

 

After nearly a month in the hospital, the pain management team consulted with us and advised us that morphine was the only way to relieve his pain. We had certainly tried everything else at our disposal. The physicians suggested a morphine drip.

 

A local hospice organization has been managing Austin’s pain with morphine ever since. Baclofen, phenobarbital and valium are still part of his medical regimen, but I believe morphine has kept him from suffering the extreme pain that he had experienced before we began this treatment. As an added benefit, Austin has gained about 30 pounds and grown in height because of his increased comfort level.

 

We also have added normal saline treatments and Atrovent to his respiratory regimen to alleviate breathing difficulties. When necessary, hospice recommends a low dose of Roxanol be added to his breathing treatment to prevent the feeling that he is suffocating.

 

While we are not sure if Austin will ever be morphine-free, we are thankful for the many days that he has been fairly comfortable.

 

Typically, when NBIA patients suffer from pain, caregivers contact primary care providers, often the patient’s neurologist. Although the doctor may feel that morphine or Roxanol may be necessary, the physician might not feel comfortable dosing to the level necessary to reach pain-free status.

 

At that point, a pain management specialist or a hospice program are options. Frequently, pain management specialists connected with children’s hospitals are familiar with narcotic levels and dosage amounts for pediatric patients and patients of rare disease. Contacting hospice does not mean that caregivers are preparing their loved ones to die. It simply means they are accessing an important resource to provide comfort.

 

It is important that before morphine is used the patient  “receive an exhaustive evaluation for a treatable cause of the pain,” said Dr. Susan Hayflick, geneticist and leading expert in NBIA at the Oregon Health & Science University. “Too often these are missed (a broken bone, bleeding stomach) and just the pain is treated.”

 

If an examination fails to reveal the cause of the pain, caregivers or patients must ask more difficult questions. Has every diagnostic tool been used and are we ready to treat the pain in the absence of understanding the cause? If the caregiver were in pain, would he or she not turn to the other person in the room and demand some sort of pain medication? Do the patients with NBIA deserve any less?

 

“Worsening pain does not indicate that the person is nearing death,” Hayflick said. “Pain episodes seem to come and go for most patients. Sometimes there is a treatable reason and sometimes not. I think there is little, if any, correlation between worsening pain and worsening disease.”

 

Many caregivers wince at the thought of morphine. They might associate the drug with end-of-life care or worry whether there will be anything stronger if needed later. Will the morphine hasten their loved one’s death?

 

Dr. Deidre Woods, medical director of Hospice of Naples, Fla., said morphine is not necessarily reserved for end of life nor does it bring on death.

 

“In fact, patients frequently express a new lease on life and are able to eat or sleep comfortably now that they are pain free,” she said. “Roxanol use in nebulizer treatments also can help a patient to breathe much easier especially when the patient suffers from the debilitating feeling of suffocating due to inspiratory strider. This brings a great deal of comfort to a patient and they can lead more productive and fulfilled lives with morphine as part of the medical treatment program.... If the patient requires less medication, we can decrease the amount of morphine until the patient is comfortable.”

 

Woods said that respiratory problems occur mainly in rare cases where extraordinary high doses are given, especially if the patient has never had these types of drugs before. It is important to start at very low doses, then increase the medication level as needed.

 

The use of morphine in NBIA patients is a subject of debate and will continue to be a topic of consideration as long as our patients continue to suffer from intense bouts of pain. While we hope for a cure, many of us will continue to seek out information on pain management. Morphine may not be the only answer, but for some NBIA patients, it is an important part of a regimen of medications that attempt to keep them pain-free.